Thomas B. Neff, Chief Executive Officer at FIBROGEN INC (FGEN), sold 39,636 shares at $55.84 ($2.2M) on 2019-03-06, disclosed to the SEC on 2019-03-08.
Seasonal sale ($2.2M) by Chief Executive Officer — this insider has traded FGEN in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.81 | 818 | $46K | 2.1% |
| 2 | $55.84 | 9,464 | $528K | 24.0% |
| 3 | $56.84 | 7,836 | $445K | 20.2% |
| 4 | $56.86 | 600 | $34K | 1.5% |
| 5 | $57.68 | 1,100 | $63K | 2.9% |
| 6 | $54.89 | 1,318 |
| $72K |
| 3.3% |
| 7 | $54.90 | 17,200 | $944K | 42.8% |
| 8 | $55.45 | 100 | $6K | 0.3% |
| 9 | $55.47 | 1,200 | $67K | 3.0% |
| Total | $55.65 avg | 39,636 | $2.2M | 100% |
| Filing → |
| FGEN | SELL | 2019-07-26 | $1.9M | — | Filing → |
| FGEN | SELL | 2019-07-12 | $1.8M | — | Filing → |
| FGEN | SELL | 2019-06-21 | $1.8M | — | Filing → |